HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-vivo iMap IVUS comparison of in-stent neointima and native coronary atherosclerosis.

AbstractPURPOSE:
The purpose of this study was to compare plaque characteristics of native coronary atherosclerosis and in-stent neointima ten months after ST elevation myocardial infarction (STEMI) using iMap intravascular ultrasound (IVUS).
METHODS:
In 49 patients in-stent neointima and the coronary segment proximal to the stent were analyzed with iMap intravascular ultrasound (IVUS) ten months after primary PCI for STEMI.
RESULTS:
A higher percentage of necrotic tissue was observed in the proximal coronary segment compared to the in-stent neointima by iMap IVUS (25.5% ± 12.8% vs 12.3% ± 3.3%, p < 0.0001) ten months after STEMI. The proportion of fibrotic tissue in the proximal segment was lower (63.6% ± 14.8% vs 72.0% ± 5.7%, p = 0.002) and the proportion of the lipidic tissue was higher (8.8% ± 3.0% vs 5.9% ± 2.0%, p < 0.0001) than in-stent neointima.
CONCLUSIONS:
In patients ten months after STEMI, in-stent neointima contained a higher proportion of fibrotic tissue and lower proportion of necrotic and lipidic tissue compared the native atherosclerotic lesion.
AuthorsKarlis Trusinskis, Karlis Strenge, Dace Juhnevica, Andrejs Erglis
JournalCardiovascular revascularization medicine : including molecular interventions (Cardiovasc Revasc Med) Vol. 16 Issue 4 Pg. 233-6 (Jun 2015) ISSN: 1878-0938 [Electronic] United States
PMID25980925 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Coronary Angiography (methods)
  • Coronary Artery Disease (diagnostic imaging)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnostic imaging)
  • Neointima (diagnostic imaging)
  • Percutaneous Coronary Intervention
  • Plaque, Atherosclerotic (diagnostic imaging, pathology)
  • Stents
  • Ultrasonography, Interventional (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: